Evaluation of Whole Body Examination by MRI Integrating the "Zero Time Eco" Sequence (ZTE, Pseudo-CT) for the Detection of Bone Lesions in Multiple Myeloma: Comparison With Pet / CT and Whole Body Scanner
NCT05381077 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2022-05-19
Summary
To assess the added value of magnetic resonance imaging (MRI) of the skeleton compared to other validated techniques for the detection of bone lesions in patients with multiple myeloma.
Conditions
Interventions
- OTHER
-
MRI
Whole body MRI (ZTE sequence)
Sponsors & Collaborators
-
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
lead OTHER
Principal Investigators
-
Frederic Lecouvet, MD-PhD · Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-02
- Primary Completion
- 2023-08-31
- Completion
- 2023-08-31
Countries
- Belgium
Study Locations
More Related Trials
-
A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma
NCT05448404 ·Status: UNKNOWN ·Phase: NA
-
Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI
NCT04493411 ·Status: TERMINATED ·Phase: NA
-
Detection of Bone Marrow Metastases With Magnetic Resonance Imaging
NCT03876392 ·Status: UNKNOWN ·Phase: NA
-
A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma.
NCT07319897 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
"WB-DCE-MRI" in Multiple Myeloma as an Independent Prognostic Factor for Disease-free Survival
NCT01171430 ·Status: COMPLETED ·Phase: NA
-
Detection and Characterization of Residual Masses in Lymphomas
NCT02300402 ·Status: COMPLETED
-
Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions
NCT06720207 ·Status: NOT_YET_RECRUITING
-
Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases
NCT04159376 ·Status: UNKNOWN ·Phase: NA
-
PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)
NCT06871176 ·Status: RECRUITING ·Phase: NA
-
Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.
NCT00200668 ·Status: TERMINATED ·Phase: NA
-
Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma
NCT06659276 ·Status: RECRUITING
-
PET Imaging Study of 68Ga-NB381 in Multiple Myeloma
NCT06385652 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma
NCT03891914 ·Status: COMPLETED ·Phase: PHASE3
-
Whole-body MR in Staging Bone and Soft Tissue Metastases in Breast Cancer Patients(MetaMaRBo)
NCT01291082 ·Status: UNKNOWN
-
Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers
NCT02966574 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
NCT02042924 ·Status: TERMINATED ·Phase: NA
-
MPDL3280A-imaging-IST-UMCG
NCT02453984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma
NCT04931875 ·Status: UNKNOWN
-
Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.
NCT05340569 ·Status: COMPLETED ·Phase: NA
-
89Zr-labeled NY008 PET Imaging in Patients
NCT05655676 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies
NCT05597215 ·Status: UNKNOWN
-
Vertebral Fat Quantitative MRI as a Marker of Bone Fragility in Multiple Myeloma (MYELOMEFRAGIQUANTI)
NCT04609150 ·Status: UNKNOWN
-
A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging
NCT06834412 ·Status: RECRUITING ·Phase: NA
-
Imaging in MGUS, SMM and MM
NCT01237054 ·Status: COMPLETED ·Phase: PHASE2
-
PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow Infiltration for Initial Staging of Lymphoma
NCT05565898 ·Status: NOT_YET_RECRUITING